Bayesian Capital Management’s Neogen NEOG Stock Holding History

Bayesian Capital Management’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,800	Closed	-$61.7K	–	392
2025 Q3	$61.7K	Buy	+10,800	New	+$57.6K	0.01%	498
2025 Q2	–	Sell	-83,657	Closed	-$725K	–	761
2025 Q1	$725K	Buy	+83,657	New	+$877K	0.12%	231
2024 Q2	–	Sell	-11,103	Closed	-$175K	–	974
2024 Q1	$175K	Buy	+11,103	New	+$186K	0.02%	672
2022 Q4	–	Sell	-110,500	Closed	-$1.54M	–	948
2022 Q3	$1.54M	Buy	+110,500	New	+$2.23M	0.31%	72
2020 Q4	–	Sell	-5,600	Closed	-$219K	–	604
2020 Q3	$219K	Buy	+5,600	New	+$214K	0.05%	426
2020 Q2	–	Sell	-14,610	Closed	-$489K	–	689
2020 Q1	$489K	Buy	+14,610	New	+$479K	0.11%	303
2017 Q1	–	Sell	-10,933	Closed	-$271K	–	612
2016 Q4	$271K	Buy	+10,933	New	+$243K	0.07%	452

Other funds holding NEOG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return

ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CWM

CIBC World Markets New York $20.8B AUM

Bayesian Capital Management's NEOG Position: Q4 2025 in Review

Bayesian Capital Management sold out of Neogen (NEOG) in Q4 2025, closing a stake of 10,800 shares — an estimated $61.7K sold.

Bayesian Capital Management first reported a position in NEOG in Q4 2016 and held it in 7 quarters. The position peaked at $1.54M in Q3 2022. 305 funds tracked by Wall St. Rank hold NEOG as of Q4 2025.

Bayesian Capital Management reported no remaining Neogen position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 10,800 Neogen shares in Q4 2025, an estimated $61.7K.
Bayesian Capital Management first reported a position in Neogen in Q4 2016 and held it in 7 quarters.
Bayesian Capital Management's Neogen position peaked at $1.54M in Q3 2022.
305 funds tracked by Wall St. Rank held Neogen as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.